Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective lowered by Morgan Stanley from $220.00 to $184.00 in a research report released on Wednesday morning,Benzinga ...

The stock's fall snapped a three-day winning streak.

This was the stock's second consecutive day of gains.

Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Charles River (CRL) to $184 from $220 and keeps an Equal Weight rating ...

Charles River Laboratories Financial Overview And Stock Metrics ...

Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The growth of the pharmaceutical analytical testing outsourcing market in Europe is propelled by several key ...

North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic ...

Charles River is shuttering its pathology facility in Durham, North Carolina, after determining the site “is not a strategic ...

Charles River Laboratories is permanently closing its pathology facility in Durham, NC, after determining it is no longer “a ...

Members of Congress and animal rights advocates believe the Department of Government Efficiency could end animal testing ...